In the spirit of continuous optimization for efficiency and effectiveness, Sundial has made some organizational changes. This has resulted in the reduction of staff positions at our Alberta operations of less than 10 per cent of our workforce.

We are doing this partially in response to challenging industry conditions, largely the because of regulatory delays that have resulted in fewer than anticipated stores across the country. This in turn has generated lower than expected sales for all players. The organizational changes will have no impact on the quality of our products.

As part of our commitment to long-term sustainable growth, it is important we remain agile in responding to the evolving cannabis market conditions by controlling costs to balance supply and demand.

We are proud of the hundreds of jobs that we have directly and indirectly created in Alberta.

About Sundial Growers Inc.

Sundial proudly crafts pioneering cannabis brands to Heal, Help and PlayTM:

◦ Heal - cannabis products used as prescription medicine
◦ Help - cannabis products that strive to promote overall Health and wellness through CBD
◦ Play - cannabis products to enhance social, spiritual and recreational occasions

We have experience in the fast-moving consumer goods industry enabling us to not just grow the finest quality cannabis, but also create exceptional consumer and customer experiences.

To craft the best and most trusted cannabis, our team of legendary growers focus on quality and consistency. We are a 'craft-at-scale' licensed producer using purpose-built modular facilities and award-winning genetics.

We currently operate two locations in Alberta, including our flagship facility in Olds and another one in Rocky View, with plans to build a third facility in British Columbia.

Media Contact:
Sophie Pilon
Corporate Communications Manager Sundial Growers Inc.
Sundial Growers Inc.
C: 1.403.815.7340
E: spilon@sundialgrowers.com

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain 'forward-looking information' within the meaning of applicable securities law ('forward-looking statements'). Forward looking statements in this release includes, but is not limited to, the potential expansion plans of the Company in Canada, the Company's ability to provide uninterrupted supply to its customer, and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'may', 'will', 'potential', 'proposed' and other similar words, or statements that certain events or conditions 'may' or 'will' occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Latest News
View All
Saturday, Jan 25, 2020 Statement To Media

In the spirit of continuous optimization for efficiency and effectiveness, Sundial has made some organizational changes. This has resulted in the reduction of staff positions at our Alberta operations.

Read More
Thursday, Jan 23, 2020 Correction to Global Article

The article that was published by Global News on January 22, 2020 contained a number of factual inaccuracies. The article was corrected and an apology was issued to Sundial.

Read More
Thursday, Jan 09, 2020 Sundial and Vir Pharmaceuticals Sign Medical Cannabis Supply Agreement for Australian Chronic Pain Clinical Studies

Sundial and Vir Pharma announced a three-year agreement where Sundial will supply medical cannabis oil for Vir Pharma's unique oral formulation for chronic pain that will be used for clinical studies in Australia.

Read More

Attachments

  • Original document
  • Permalink

Disclaimer

Sundial Growers Inc. published this content on 25 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2020 22:14:02 UTC